CDKN1A and familial pancreatic carcinoma: To the best of our knowledge, no data are available about molecular p21 involvement in MDM2 inhibitor effects except in p21-downregulated pancreatic cancer cells, in which the block of the apoptotic potential by the MDM2 inhibitor MI-319 has been demonstrated [19].